Literature DB >> 3455075

Male-enhanced expression and genetic conservation of a gene isolated with an anti-H-Y antibody.

Y F Lau1, K M Chan, Y W Kan, E Goldberg.   

Abstract

The hypothesis of the serological H-Y antigen as the inducer molecule for mammalian male sex differentiation has been considered an important working model in developmental biology. However, because of the difficulties involved in its detection, supporting evidence in molecular terms is lacking for this hypothesis. The isolation of the gene for the serological H-Y antigen is essential to the acertainment of its proposed functions. Using recombinant DNA technology and specific anti-H-Y sera we have isolated a candidate gene, the MEA gene, for the serological H-Y antigen. Molecular characterization of the MEA gene shows male-enhanced expression and genetic conservation patterns similar to those attributed to the serological H-Y antigen. The isolation of this candidate gene for the serological H-Y antigen. The isolation of this candidate gene for the serological H-Y antigen would allow further investigations to identify the functions for this molecule in molecular terms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3455075

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


  3 in total

1.  Male-enhanced antigen gene is phylogenetically conserved and expressed at late stages of spermatogenesis.

Authors:  Y F Lau; K M Chan; R Sparkes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  The putative testis-determining factor and related genes are expressed as discrete-sized transcripts in adult gonadal and somatic tissues.

Authors:  Y F Lau; K M Chan
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

3.  New point mutation in Golga3 causes multiple defects in spermatogenesis.

Authors:  L F Bentson; V A Agbor; L N Agbor; A C Lopez; L E Nfonsam; S S Bornstein; M A Handel; C C Linder
Journal:  Andrology       Date:  2013-03-15       Impact factor: 3.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.